Figure 2: Body Weight Reductions with GLP-1 RA in Head-to-head Clinical Studies.

p Values are for statistical superiority (unless noted for non-inferiority); *p=not significant; †p=0. 0005; ‡p value not reported for weight difference of 1.02 kg (95 % confidence interval 0.456–1.581); ^§p<0.0001; ^¶p<0.001 versus dulaglutide 0.75 mg; **p=not significant between dulaglutide 1.5 mg versus exenatide bid; ‡‡p=0.011. GLP-1 RA = glucagon-like peptide-1 receptor agonists. Reproduced with permission from Trujillo et al., 2015.¹⁷